Diagnostic value of cystatin C and neutrophil gelatinase-associated lipocalin in primary glomerulopathies

Terapevticheskii Arkhiv

Volumn 85, Issue 6, 2013, Pages 10-16

  Proletov, Ya Yu ^a   Saganova, E S ^a   Galkina, O V ^b   Zubina, I M ^b   Bogdanova, E O ^b   Sipovsky, V G ^b   Smirnov, A V ^a,b  

^a Department of Internal Propedeutics ^*  (Russian Federation)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Biomarkers; Chronic kidney disease; Cystatin C; Glomerulonephritis; Neutrophil gelatinase associated lipocalin

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CYSTATIN C; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADULT; ARTICLE; BIOPSY; BLOOD; COMPARATIVE STUDY; FEMALE; GLOMERULONEPHRITIS; HUMAN; KIDNEY FUNCTION TEST; MALE; PATHOLOGY; PREDICTIVE VALUE; URINE;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; BIOPSY; CYSTATIN C; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY FUNCTION TESTS; LIPOCALINS; MALE; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS;

EID: 84881342404     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. De Geus H. R., Betjes M. G, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J 2012;5(2):102-108.
2. Bolignano D., Coppolino G., Campo S. et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant 2008;23(1):414-416.
3. Bolignano D., Lacquaniti A., Coppolino G. et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009;4(2):337-44.
4. Fassett R. G., Venuthurupalli S. K., Gobe G. C. et al. Biomarkers in chronic kidney disease: a review. Kidney Int 2011;80(8):806-821.
5. BohleA., Mackensen-Haen S., Von Gise H. et al. The consequences of tubule-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 1990;186(1):135-144.
6. Dharnidharka V. R., Kwong C., Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 2002;40(2):221-226.
7. Viau A., El Karoui K., Laouari D. et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest 2010;120(11):4065-4076.
8. Bolignano D., Coppolino G., Lacquaniti F. et al. Pathological and Prognostic Value of Urinary Neutrophil Gelatinase-Associated Lipocalin in Macroproteinuric Patients with Worsening Renal Function. Kidney Blood Press Res 2008;31(4):274-279.
9. Spanaus K. S., Kollerits B., Ritz E. et al. Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. Clin Chem 2010;56(5):740-749.
10. Nickolas T. L., Forster C. S., Sise M. E. et al. NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease. Kidney Int 2012;82(6):718-722.
11. Ding H, He Y., Lia K. et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 2007;123(2):227-234.
12. Hoek F. J., Kemperman F. A., Krediet R. T. A comparison between cystatin C, plasma creatinine and the Cockroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003;18:2024-2031
13. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Supplements 2013:1.
14. Conti M., Moutereau S., Zater M. et al. Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med 2006;44(3):288-291.
15. Herget-Rosenthal S., Van Wijk J A., Brocker-Preuss M. et al. Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin Biochem 2007;40(13-14):946-951.
16. Mori K., Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007;71(10):967-970.
17. Bolignano D., Donato V., Coppolino G. et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Marker of Kidney Damage. Am J Kidney Dis 2008;51(3):595-603.
18. Abbate M., Zoja C., Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006;17(11):2974-2984.
19. Thielemans N., Lauwerys R., Bernard A. Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies. Nephron 1994;66(4):453-458.
20. Nejat M., Hill J. V., Pickering J. et al. Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrol Dial Transplant 2011;26(5):1553-1558.
21. Haase M., Bellomo R., Devarajan P. et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and metaanalysis. Am J Kidney Dis 2009;54(6):1012-1024.
22. Rauen T., Weiskirchen R., Floege J. In search of early events in the development of chronic kidney disease: the emerging role for lipocalin-2/NGAL. Nephrol Dial Transplant 2011;26(2):445-447.
23. Inker L. A., Schmid C. H., TtghiouartH. et al. Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C. N Engl J Med 2012;367(1):9-20.